These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparison of FDG PET/MRI and FDG PET/CT in Pediatric Oncology in Terms of Anatomic Correlation of FDG-positive Lesions. Uslu-Beşli L; Atay Kapucu LÖ; Karadeniz C; Akdemir ÜÖ; Pinarli FG; Aydos U; Okur A; Kaya Z; Samanci C; Karabacak NI J Pediatr Hematol Oncol; 2019 Oct; 41(7):542-550. PubMed ID: 30933019 [TBL] [Abstract][Full Text] [Related]
10. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma. Lee JW; Nam SB; Kim SJ Oncology; 2019; 97(5):286-293. PubMed ID: 31437839 [TBL] [Abstract][Full Text] [Related]
12. On Semiquantitative Methods for Assessing Vascular Laffon E; Marthan R J Nucl Med; 2022 Feb; 63(2):325-326. PubMed ID: 34475239 [No Abstract] [Full Text] [Related]
13. Imaging spectrum and pitfalls of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis. Ito K; Morooka M; Minamimoto R; Miyata Y; Okasaki M; Kubota K Jpn J Radiol; 2013 Aug; 31(8):511-20. PubMed ID: 23719763 [TBL] [Abstract][Full Text] [Related]
14. Will FAPI PET/CT Replace FDG PET/CT in the Next Decade? Counterpoint-No, Not So Fast! Moradi F; Iagaru A AJR Am J Roentgenol; 2021 Feb; 216(2):307-308. PubMed ID: 32755204 [No Abstract] [Full Text] [Related]
15. Current clinical status of Nakajo M; Kajiya Y; Jinguji M; Nakabeppu Y; Nakajo M; Nihara T; Yoshiura T Abdom Radiol (NY); 2017 Mar; 42(3):951-961. PubMed ID: 27770160 [TBL] [Abstract][Full Text] [Related]
16. Government funding of fluorodeoxyglucose positron emission tomography (FDG-PET) in rare urological cancers: better data, better outcomes. Xu J; Al Saffar H; O'Brien J; Kelly B; Lawrentschuk N BJU Int; 2024 Feb; 133 Suppl 3():8-9. PubMed ID: 37467147 [No Abstract] [Full Text] [Related]
20. Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review. Treglia G; Sadeghi R; Del Sole A; Giovanella L Clin Transl Oncol; 2014 Sep; 16(9):770-5. PubMed ID: 24647843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]